{
  "id": "ngn_mcq_mission_500_163",
  "questionType": "multipleChoice",
  "caseId": "mission_500_163_1771351853917",
  "itemStem": "The nurse is reviewing the client's electronic health record (EHR). Which action is the nurse's immediate priority?",
  "options": [
    {
      "id": "opt_04",
      "text": "Request an urgent psychiatric consultation for uncontrolled agitation."
    },
    {
      "id": "opt_02",
      "text": "Withhold the scheduled dose of risperidone and notify the healthcare provider."
    },
    {
      "id": "opt_03",
      "text": "Place the client on continuous pulse oximetry and initiate seizure precautions."
    },
    {
      "id": "opt_01",
      "text": "Administer the available PRN acetaminophen for fever."
    }
  ],
  "correctAnswer": "opt_02",
  "scoringModel": "+/-",
  "exhibits": [
    {
      "id": "exhibit_1",
      "type": "NursesNotes",
      "title": "Nurses' Notes",
      "data": {
        "timestamp": "12:00",
        "note": "Client is an 82-year-old male with a history of Alzheimer's dementia, hypertension, and hyperlipidemia, transferred from a long-term care facility (LTCF) for 'worsening agitation and confusion' over the past 48 hours. Report from LTCF was brief due to staffing challenges; noted that client was started on risperidone one week ago for behavioral disturbances. \n\nOn assessment, client is diaphoretic, minimally responsive to verbal stimuli. Opens eyes to painful stimuli. Significant 'lead pipe' rigidity noted in all extremities. Intermittent tremors observed in upper limbs. Skin is hot and dry."
      }
    },
    {
      "id": "exhibit_2",
      "type": "VitalSigns",
      "title": "Vital Signs & Diagnostics",
      "data": {
        "headers": [
          "Time",
          "Temperature",
          "Heart Rate",
          "Blood Pressure",
          "Respiratory Rate",
          "SpO2 (Room Air)"
        ],
        "rows": [
          [
            "0800",
            "38.1°C (100.6°F)",
            "98 bpm",
            "155/90 mmHg",
            "20/min",
            "95%"
          ],
          [
            "1000",
            "39.2°C (102.6°F)",
            "110 bpm",
            "170/100 mmHg",
            "24/min",
            "94%"
          ],
          [
            "1200",
            "40.1°C (104.2°F)",
            "128 bpm",
            "130/85 mmHg",
            "28/min",
            "93%"
          ]
        ],
        "footer": "ECG Interpretation: Sinus tachycardia, no acute ST changes."
      }
    },
    {
      "id": "exhibit_3",
      "type": "LabsAndMedications",
      "title": "Laboratory Results & MAR",
      "data": {
        "labs": [
          {
            "name": "White Blood Cell (WBC) Count",
            "value": "18,500/mm³",
            "reference": "4,500-11,000/mm³"
          },
          {
            "name": "Creatine Kinase (CK)",
            "value": "12,000 U/L",
            "reference": "30-200 U/L"
          },
          {
            "name": "Blood Urea Nitrogen (BUN)",
            "value": "35 mg/dL",
            "reference": "7-20 mg/dL"
          },
          {
            "name": "Creatinine",
            "value": "1.8 mg/dL",
            "reference": "0.6-1.2 mg/dL"
          },
          {
            "name": "Potassium",
            "value": "5.2 mEq/L",
            "reference": "3.5-5.0 mEq/L"
          },
          {
            "name": "Troponin I",
            "value": "<0.04 ng/mL",
            "reference": "<0.04 ng/mL"
          }
        ],
        "mar": [
          {
            "medication": "Risperidone 1 mg PO BID",
            "instructions": "Scheduled",
            "status": "DUE NOW"
          },
          {
            "medication": "Lisinopril 10 mg PO daily",
            "instructions": "Scheduled",
            "status": "Administered at 0900"
          },
          {
            "medication": "Atorvastatin 20 mg PO daily",
            "instructions": "Scheduled",
            "status": "Administered at 0900"
          },
          {
            "medication": "Acetaminophen 650 mg PO PRN",
            "instructions": "q4h for fever >38.5°C",
            "status": "Available"
          }
        ]
      }
    }
  ],
  "answerBreakdown": {
    "rationale": "The client's clinical presentation strongly suggests Neuroleptic Malignant Syndrome (NMS), a rare but life-threatening reaction to antipsychotic medications like risperidone. NMS is characterized by hyperthermia, muscle rigidity, altered mental status, and autonomic dysfunction. \n\n*   **Pathophysiology of NMS:** NMS is thought to be caused by a sudden reduction in dopamine activity in the brain, particularly in the hypothalamus and basal ganglia. Dopamine plays a crucial role in regulating body temperature, muscle tone, and autonomic functions. When dopamine is blocked, it leads to:\n    *   **Hyperthermia:** Disruption of hypothalamic thermoregulation causes a rapid and uncontrolled rise in body temperature.\n    *   **Muscle Rigidity:** Dopamine blockade in the basal ganglia leads to increased muscle tone and rigidity, often described as 'lead pipe' rigidity.\n    *   **Altered Mental Status:** Dopamine deficiency affects cognitive function, resulting in confusion, agitation, or even coma.\n    *   **Autonomic Instability:** Disruption of dopamine's role in the autonomic nervous system causes fluctuations in blood pressure, heart rate, and respiratory rate, as well as diaphoresis.\n\nThe elevated Creatine Kinase (CK) indicates rhabdomyolysis, a breakdown of muscle tissue that releases large amounts of CK into the bloodstream. This can lead to acute kidney injury, as evidenced by the elevated BUN and creatinine levels. Leukocytosis (elevated WBC count) is a common finding in NMS due to the body's stress response.\n\nThe immediate priority is to discontinue the risperidone to prevent further dopamine blockade and worsening of the syndrome. Supportive care, such as cooling measures, IV fluids, and medications like dantrolene or bromocriptine, will be necessary to manage the symptoms and prevent complications.",
    "optionsRationale": [
      {
        "optionId": "opt_01",
        "rationale": "Incorrect. Administering acetaminophen addresses the hyperthermia but does not treat the underlying cause of NMS. The fever in NMS is centrally mediated and may not respond well to antipyretics. Addressing the root cause (stopping the risperidone) is the priority.",
        "correctness": "incorrect"
      },
      {
        "optionId": "opt_02",
        "rationale": "Correct. The client's symptoms and lab results are highly indicative of NMS, likely triggered by the risperidone. The priority is to immediately discontinue the medication to prevent further progression of the syndrome. Notifying the healthcare provider is essential for further management and supportive care.",
        "correctness": "correct"
      },
      {
        "optionId": "opt_03",
        "rationale": "Incorrect. While monitoring oxygen saturation and implementing seizure precautions are important supportive measures, they do not address the underlying cause of NMS. The priority is to stop the offending medication.",
        "correctness": "incorrect"
      },
      {
        "optionId": "opt_04",
        "rationale": "Incorrect. The client's agitation is likely a symptom of NMS, not a primary psychiatric issue. Requesting a psychiatric consultation without addressing the medical emergency could delay essential treatment and potentially lead to further harm.",
        "correctness": "incorrect"
      }
    ]
  },
  "clinicalPearl": "Neuroleptic Malignant Syndrome (NMS) is a medical emergency. Remember the key features: FEVER (Fever, Encephalopathy, Vitals unstable, Elevated enzymes, Rigidity). Early recognition and discontinuation of the offending medication are crucial for improving patient outcomes. Dantrolene and bromocriptine are commonly used to treat NMS by reducing muscle rigidity and restoring dopamine activity, respectively.",
  "sbar": {
    "situation": "0800: The nurse is caring for an 82-year-old male with a history of Alzheimer's dementia, hypertension, and hyperlipidemia who was transferred from a long-term care facility for worsening agitation and confusion.",
    "background": "0805: The client was started on risperidone one week ago for behavioral disturbances. Current vital signs include a temperature of 40.1°C (104.2°F), heart rate of 128 bpm, blood pressure of 130/85 mmHg, and respiratory rate of 28/min. Laboratory results show elevated WBC, CK, BUN, and Creatinine. The client is diaphoretic and exhibits 'lead pipe' rigidity.",
    "assessment": "0810: The client is likely experiencing Neuroleptic Malignant Syndrome (NMS) secondary to risperidone.",
    "recommendation": "0815: Immediately withhold the scheduled 1 mg PO BID dose of risperidone and notify the healthcare provider. Prepare for supportive care measures, including potential administration of dantrolene or bromocriptine, IV fluids, and cooling measures. Continuous monitoring of vital signs and oxygen saturation is also recommended."
  },
  "sentinelStatus": "healed_v2026_v8"
}